EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles

Anindya Mukhopadhya iD, Dimitrios Tsiapalis, Niamh McNamee, Brian Talbot, Lorraine O'Driscoll iD

Pharmaceutics · 21.02.2023 · 15 (3) · 718

DOI: 10.3390/pharmaceutics15030718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 21.02.2023. Verfasst von Anindya Mukhopadhya und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Research Council, Trinity College Dublin Dean's Research Award, Horizon 2020 Research and Innovation Award EVPRO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) have great potential as drug delivery vehicles. While mesenchymal/stromal stem cell (MSC) conditioned medium (CM) and milk are potentially safe and scalable sources of EVs for this purpose, the suitability of MSC EVs and milk EVs as drug delivery vehicles has never been compared and so was the objective of this study. Here EVs were separated from MSCs’ CM and from milk and were characterised by nanoparticle tracking analysis, transmission electron microscopy, total protein quantification, and immunoblotting. An anti-cancer chemotherapeutic drug, doxorubicin (Dox), was then loaded into the EVs by one of three methods: by passive loading or by active loading by either electroporation or sonication. Dox-loaded EVs were analysed by fluorescence spectrophotometer, high-performance liquid chromatography (HPLC), and imaging flow cytometer (IFCM). Our study showed that EVs were successfully separated from the milk and MSC CM, with significantly (p < 0.001) higher yields of milk EVs/mL starting material compared to MSC EVs/mL of starting material. Using a fixed amount of EVs for each comparison, electroporation achieved significantly more Dox loading when compared to passive loading (p < 0.01). Indeed, of 250 µg of Dox made available for loading, electroporation resulted in 90.1 ± 12 µg of Dox loading into MSC EVs and 68.0 ± 10 µg of Dox loading into milk EVs, as analysed by HPLC. Interestingly, compared to the passive loading and electroporation approach, after sonication significantly fewer CD9+ EVs/mL (p < 0.001) and CD63+ EVs/mL (p < 0.001) existed, as determined by IFCM. This observation indicates that sonication, in particular, may have detrimental effects on EVs. In conclusion, EVs can be successfully separated from both MSC CM and milk, with milk being a particularly rich source. Of the three methods tested, electroporation appears to be superior for achieving maximum drug loading while not causing damage to EV surface proteins.

Schlagwörter

Stichwörter der Autor:innen

HPLCdoxorubicindrug-loadingelectroporationextracellular vesiclesimaging flow cytometrymesenchymal/stromal stem cellsmilksonication

Autor:innen und Institutionen

  • School of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland.
  • Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland.
  • Trinity St. James's Cancer Institute, D08 W9RT Dublin, Ireland.

ORCID-Profile: Anindya Mukhopadhya, Lorraine O'Driscoll

Förderung

  • Irish Research Council
  • Trinity College Dublin Dean's Research Award
  • Horizon 2020 Research and Innovation Award EVPRO
  • Research Council Advanced Laureate Award EVIC
  • Trinity College Dublin Dean’s Research Award

Zitieren

APA

Mukhopadhya, A., Tsiapalis, D., McNamee, N., Talbot, B., & O'Driscoll, L. (2023). Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles. Pharmaceutics, 15(3), 718. https://doi.org/10.3390/pharmaceutics15030718

Vancouver

Mukhopadhya A, Tsiapalis D, McNamee N, Talbot B, O'Driscoll L. Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles. Pharmaceutics. 2023;15(3):718. doi:10.3390/pharmaceutics15030718

BibTeX
@article{Mukhopadhya2023,
  author = {Mukhopadhya, Anindya and Tsiapalis, Dimitrios and McNamee, Niamh and Talbot, Brian and O'Driscoll, Lorraine},
  title = {Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {718},
  doi = {10.3390/pharmaceutics15030718}
}
Kostenlos starten →